Dr. Colvin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
Pathology Associates
Boston, MA 02114Phone+1 617-726-2966Fax+1 617-726-7533
Education & Training
- Massachusetts General HospitalResidency, Pathology-Anatomic and Clinical, 1969 - 1972
- Massachusetts General HospitalInternship, Transitional Year, 1968 - 1969
- Harvard Medical SchoolClass of 1968
Certifications & Licensure
- MA State Medical License 1969 - 2025
- NH State Medical License 2015 - 2021
- American Board of Pathology Anatomic Pathology
- American Board of Pathology Immunopathology
Publications & Presentations
PubMed
- Corrigendum to "Quantitative scoring of progression in transplant glomerulopathy using digital pathology may be superior to Banff cg scoring." Kidney International 202...Željko Kikić, Benjamin A Adam, Anna Buxeda, Carmen Lefaucheur, Alexandre Loupy
Kidney International. 2024-10-01 - Relevance of the Banff Human Organ Transplant Consensus Gene Panel for Detecting Antibody and T-Cell-Mediated Rejection of Kidney Allografts.Alessia Giarraputo, Valentin Goutaudier, Blaise Robin, Annalisa Angelini, Marta Sablik
Kidney International Reports. 2024-07-01 - 1 citationsDysfunction of infiltrating cytotoxic CD8+ T cells within the graft promotes murine kidney allotransplant tolerance.Takahiro Yokose, Edward S Szuter, Ivy Rosales, Michael T Guinn, Andrew S Liss
The Journal of Clinical Investigation. 2024-06-18
Journal Articles
- Case 34-2020: A 74-Year-Old Man with Chronic Kidney DiseaseEugene P Rhee, Rahul Sakhuja, Robert B Colvin, The New England Journal of Medicine
Press Mentions
- CANbridge Forms Scientific Advisory Board to Guide Global Development of CAN106 in Complement-Mediated DiseasesJuly 6th, 2022
- SeQure Dx Announces $17.5M Series A FundingAugust 3rd, 2021
- SeQure Dx Raises $17.5M in Series A FundingAugust 3rd, 2021
- Join now to see all
Grant Support
- Mechanisms Of Acceptance In Mouse Renal AllograftsNational Institute Of Allergy And Infectious Diseases2010–2012
- ImmunopathologyNational Heart, Lung, And Blood Institute2009–2012
- PathologyNational Institute Of Allergy And Infectious Diseases2010–2011
- Mechanisms Of Acceptance Of Mouse Renal AllograftsNational Institute Of Allergy And Infectious Diseases2009
- Core--PathologyNational Institute Of Allergy And Infectious Diseases2005–2009
- Core--ImmunopathologyNational Heart, Lung, And Blood Institute1998–2002
- Molecular Immunology And Tumor BiologyNational Cancer Institute1995–1997
- Cell Interaction And The Clotting SystemNational Cancer Institute1988–1995
- Immunology And TumorsNational Cancer Institute1985–1994
- Cell Interaction And The Clotting SystemNational Cancer Institute1985–1987
- Flow Cytometry--CoreNational Heart, Lung, And Blood Institute1985
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: